New Programs Added in Antibody Collaboration Between XOMA (US) LLC and Takeda Pharmaceutical Co. Ltd.

BERKELEY, Calif., Sept. 15, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today the initiation of new therapeutic antibody programs under an existing antibody discovery and development collaboration between Takeda and XOMA. The new programs add to the multiple discovery and development programs already being advanced through the collaboration.

Back to news